|
STAB ROOM STUDIES
Airway
Study (Intubation)
Central
Line Study
Shock Study
BAY STUDIES
Alcohol Intoxication Study
Carbon Monoxide Study
Electronic
Asthma Action Plan
HIV Study BLITZ
Pelvic Ultrasound
Propofol versus Alfentanil versus Nitrous Oxide
Overview: A study designed to determine if
there is significance between certain events and the timing of such
events in patients receiving an oral airway in the stab
room
Study Endpoints: Timing of procedures during
and immediately following the placement of an oral airway.
This will be done using stopwatches located in the media room.
Eligible Patients: Any patient in the Stab Room
receiving an oral airway (being intubated). Consent will not be
possible for most patients.
Study Design: Prospective, observational trial
Anticipated Benefits: None
Potential Risks: None
Research Associate’s Role: Identify and (if
possible) consent potential patients. Obtain times of certain
events listed on the datasheet.
Physician’s Role: The RA may ask you to notify
them of any eligible patients.
Location of Study Packets: In Stab Room
(stopwatches are in media room)
http://en.wikipedia.org/wiki/Intubation
http://en.wikipedia.org/wiki/Etomidate
[Back to Top]
Overview: This study seeks to investigate
the efficiency of central line placements in the emergency
department
Primary Endpoints: Identify eligible
patients and determine which forms the Dr. should fill out
Eligible Patients: Any patient who is having
central line placed or has had one placed recently.
Study Design: Prospective observational trial
Anticipated Benefits: none
Potential Risks: none
Research Associate’s Role: RA’s are responsible
for identifying patients and noting the amount of times a placement is
attempted (complete form A for every patient; complete form B for every
attempt at placement, whether successful or not - separate attempts
defined as 1) different physician attempting to place the line or 2)
attempting to place the line at a new anatomical position)
Physician’s Role: Physicians will be asked to
fill out forms as needed
Location of Study Packets: All Team Centers and
Media Room
http://en.wikipedia.org/wiki/Central_venous_catheter
[Back to Top]
Overview: This study is designed to
determine if information provided by the tissue perfussion monitor
represents a patient's subsequent hospitalization and if it aids in
resusitation.
Primary Endpoints: StO2, disposition, length
of ICU stay
Eligible Patients: Patients with a systolic
blood pressure of less than 95 or a shock index greater than .90.
Study Design: Prospective observational trial
Anticipated Benefits: none
Potential Risks: none
Research Associate’s Role:
RA’s are responsible for identifying eligible patients, hooking them up
to the tissue perfusion monitor and collecting data.
Physician’s Role: Physicians will be asked to
answer questions regarding the patient's condition and resusitation.
Location of Study Packets: Media Room
[Back to Top]
The alcohol intoxication study enrolls all patients who are
intoxicated in the emergency department. The nurse or physician
evaluates the patient's condition before they know the patient's blood
alcohol level to assess the utility of the blood alcohol level in the
healthcare setting.
[Back to Top]
Overview: A
study designed to determine if there is significance between labs drawn
from a patient with potential CO poisoning and End Tidal levels
Study Endpoints: Carboxyhemoglobin levels drawn;
End Tidal levels taken close to time when labs are drawn
Eligible Patients:
18 or older; suspected CO exposure. If they can give consent, STAB
patients are eligible!! Look for chief complaints of CO exposure,
dizziness, lightheadedness, etc...
Study Design: Prospective, observational trial
Anticipated Benefits: None
Potential Risks: None
Research Associate’s Role:
Identify and consent potential CO patients. Record carboxyhemoglobin
lab levels by looking up labs on EmStat (or ask PMP). Obtain End Tidal
levels with ETCO2 monitor; get one reading as close as possible to time
labs are being drawn.
Physician’s Role: RA may ask for
carboxyhemoglobin lab levels and PMP/nurse is responsible for drawing
labs (as they normally would)
Location of Study Packets:
Team Center B (center island) The datasheet is a half sheet of paper.
Staple it to the consent form when finished. Please put completed
studies into the "Completed Studies" box in Team B
Monitor Directions:
Directions for Capnography Monitor (Square machine):
1) Make sure machine is plugged in. Attach cannula (orange
end) to left side.
2) Attach cannula to patient.
http://en.wikipedia.org/wiki/Carbon_monoxide_poisoning
http://en.wikipedia.org/wiki/Carboxyhemoglobin
[Back to Top]
Purpose: The purpose of
this study is to assess the incidence of new HIV cases currently
unidentified in the ED and the feasibility/application of rapid HIV
testing in the ED.
Study Design: Prospective, observational - during random times
throughout the day
Anticipated Benefits: Knowing
HIV status.
Anticipated Risks: None
Research Associate's Role: During
the blitz times, to approach eligible patients in the the emergency
department with information regarding the HIV study, ask risk
assessment questions, and deliver negative HIV test results.
[Back to Top]
Purpose: The purpose of this
study is to investigate the satisfaction of newly mounted pelvic
ultrasound machines in specific patient rooms.
Study Design: Prospective, observational
Anticipated Benefits: None
Potential Risks: None
Research Associate’s Role: Identify patients
that get a pelvic ultrasound by use of the new mounted machines and ask
the patient and physician performing/overseeing ultrasound survey
questions.
Location of Study Packets:
Media room
[Back to Top]
Overview: A study designed to determine
and compare the efficacy and safety of propofol versus alfentanil
versus nitrous oxide for moderate and deep sedations.
Study Endpoints: Respiratory depression as
assessed by ETCO2. Mental status as assessed by OAAS and patient report.
Eligible Patients: Adult (≥18 y.o.) patients
undergoing a procedural sedation for any reason.
Study Design: Prospective, observational
trial.
Anticipated Benefits: BIS and ETCO2 monitoring
mandated by the study may improve safety of procedure.
Potential Risks: The usual risks associated with
sedation.
Research Associate’s Role: The RA is responsible
for identifying, enrolling, and collecting data from eligible patients
for this study. The RA is in charge of setting up and putting
away the BIS and End-Tidal CO2 monitor used to obtain data during the
procedure. After the study, the RA conducts interviews of the
physician and the patient.
Physician’s Role: The RA will ask you to notify
them of any conscious sedations being performed so that they may enter
the patient into the study. Once the procedure is over, the
physician will be asked to complete a short questionnaire about the
success of the procedure.
Location of Study Packets: Media Room
[Back to Top]
|